Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
12.77
-0.38 (-2.89%)
Mar 31, 2025, 1:37 PM EDT - Market open
Delcath Systems Market Cap
Delcath Systems has a market cap or net worth of $426.56 million as of March 31, 2025. Its market cap has increased by 405.40% in one year.
Market Cap
426.56M
Enterprise Value
387.06M
1-Year Change
405.40%
Ranking
Category
Stock Price
$12.77
Market Cap Chart
Since May 10, 2018, Delcath Systems's market cap has increased from $2.70M to $426.56M, an increase of 15,698.45%. That is a compound annual growth rate of 108.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 439.30M | 14.10% |
| Dec 31, 2024 | 385.00M | 319.85% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 9,125.00% |
| Dec 31, 2019 | 800.00K | -68.00% |
| Dec 31, 2018 | 2.50M | -7.41% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.71B |
| UnitedHealth Group | 473.87B |
| Johnson & Johnson | 394.99B |
| AbbVie | 363.93B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 227.73B |
| Merck & Co. | 226.03B |
| AstraZeneca | 225.00B |